Abstract:BackgroundTissue factor pathway inhibitor-1 (TFPI-1) has multiple functions and its precise role and molecular mechanism during the development of atherosclerosis are not clear.ObjectivesTo determine the effect and molecular mechanism of TFPI-1 deficiency in vascular smooth muscle cells (VSMCs) in atherosclerosis in the apolipoprotein E knockout (ApoE−/−) mouse.Methods and resultsA mouse model with a conditional knockout of TFPI-1 in VSMCs in an atherosclerosis-prone background (ApoE−/−) was generated. Mice were fed a high fat diet for 18weeks and were then euthanized. Arterial trees and aortas were stained with Sudan IV and were labeled via immunohistochemistry. Cell proliferation and migration of VSMCs in atherosclerotic plaques were assessed. More atherosclerotic lesions and higher levels of proliferation and migration of VSMCs were observed in TFPI-1fl/fl/Sma-Cre+ApoE−/−mice. An interaction between TFPI-1 and angiomotin (AMOT) was identified in human VSMCs by mass spectrometry, immunoprecipitation and co-localization analyses. Signal pathway changes were detected by Western blot analysis, and the expression levels of target genes were determined by real-time PCR. Decreased phosphorylation of AMOT and Yes-associated protein 1 (YAP) in TFPI-1fl/fl/Sma-Cre+ApoE−/− mice resulted in increased expression levels of snail family zinc finger 2 (SLUG) and connective tissue growth factor (CTGF), which are target genes of the Hippo signaling pathway that have been verified as atherosclerosis candidate genes.ConclusionDeficiency in TFPI-1 in the VSMCs of ApoE−/− mice accelerated the development of atherosclerosis by promoting the proliferation and migration of VSMCs which may be caused by the decreased phosphorylation of AMOT and YAP.SignificanceTFPI-1 has been found to has an anticoagulant activity, induce cell apoptosis and prevent cell proliferation. For the first time, we constructed a line of conditional knockout mice in which the TPFI-1 gene is deleted in VSMCs. We found that TFPI-1 deficiency clearly promoted the development of atherosclerosis when these mice were crossed into an ApoE−/−background. One notable feature of atherosclerosis is the proliferation and migration of smooth muscle cells. Previous reports involved TFPI-1 do not completely explain the proliferation and migration of VSMCs because heterozygous TF deficient (TF±) mice bred in an ApoE−/− background did not show diminished atherosclerosis compared to TF+/+ mice bred in the same background. Our results first confirmed that TFPI-1 interacts with AMOT, which led to a decrease in the phosphorylation of YAP and further increased the genes expression of the proliferation and migration involved. Our results further confirmed that atherosclerosis was a localized disease.

ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease

Feedback Regulation of Coronary Artery Disease Susceptibility Gene ADTRP and LDL Receptors LDLR/CD36/LOX-1 in Endothelia Cell Functions Involved in Atherosclerosis

CTRP1, an Adipokine Causing Endothelial Dysfunction Through Upregulation of Arginase 1, is Associated With the Severity of Coronary Artery Disease in Patients and Promotes Atherogenesis in Mice

Association Study to Evaluate Tfpi Gene in Cad in Han Chinese

PHACTR1, a pro-atherosclerotic mechanosensitive PPARgamma corepressor in endothelial cells

Abstract 12876: Post-Transcriptional Regulation of Cardiac Fatty Acid Metabolism by the Tandem Zinc Finger Mrna Binding Protein Tristetraprolin

Abstract 346: 9p21.3 Coronary Artery Disease Risk Variants Disrupt Tead Transcription Factor Binding and Tead-dependent Tgfβ Induction of P16 Expression

PHACTR1, a coronary artery disease risk gene, mediates endothelial dysfunction

Endothelial PHACTR1 Promotes Endothelial Activation and Atherosclerosis by Repressing PPARγ Activity Under Disturbed Flow in Mice

C1q/TNF-related Protein-1: an Adipokine Marking and Promoting Atherosclerosis

Endothelial PHACTR1 Promotes Endothelial Activation and Atherosclerosis by Repressing PPAR & gamma; Activity Under Disturbed Flow in Mice

Trna-Derived Small Non-Coding RNAs As Novel Epigenetic Molecules Regulating Adipogenesis

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity

The Role of Transcription Factors in Coronary Artery Disease and Myocardial Infarction

TCF21 and AP-1 interact through epigenetic modifications to regulate coronary artery disease gene expression

Conditional Knockout of TFPI-1 in VSMCs of Mice Accelerates Atherosclerosis by Enhancing AMOT/YAP Pathway.

Atheroprotective Flow Upregulates ITPR3 (inositol 1,4,5-Trisphosphate Receptor 3) in Vascular Endothelium Via KLF4 (Krüppel-Like Factor 4)-Mediated Histone Modifications

Tissue Factor Pathway Inhibitor-2 Gene Polymorphisms Associate with Coronary Atherosclerosis in Chinese Population.

Hepatic ADTRP overexpression does not influence lipid and glucose metabolism

Clinical study of the association between tissue factor pathway inhibitor 2 (TFPI-2) gene polymorphisms and acute coronary syndrome

Identification of the Transcription Factor ATF3 as a Direct and Indirect Regulator of the LDLR